AVITA Medical, Inc. (AVH.AX)
AUD 2.87
(-3.69%)
AUD 2.87
(-3.69%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2022 | 55.88 Million USD | -21.9% |
| 2021 | 71.55 Million USD | 43.62% |
| 2020 | 49.82 Million USD | -7.68% |
| 2019 | 53.96 Million USD | 84.5% |
| 2018 | 29.25 Million AUD | 39.5% |
| 2017 | 20.96 Million AUD | 34.39% |
| 2016 | 15.6 Million AUD | 45.21% |
| 2015 | 10.74 Million AUD | 40.3% |
| 2014 | 7.65 Million AUD | -11.97% |
| 2013 | 8.69 Million AUD | -17.8% |
| 2012 | 10.58 Million AUD | 9.68% |
| 2011 | 9.64 Million AUD | 22.37% |
| 2010 | 7.88 Million AUD | 50.68% |
| 2009 | 5.23 Million AUD | -11.52% |
| 2008 | 5.91 Million AUD | 2.81% |
| 2007 | 5.75 Million AUD | -34.27% |
| 2006 | 8.75 Million AUD | -9.03% |
| 2005 | 9.62 Million AUD | 0.0% |
| 2003 | 4.86 Million AUD | 2772.4% |
| 2002 | 169.38 Thousand AUD | -74.72% |
| 2001 | 670 Thousand AUD | 771.65% |
| 2000 | 76.86 Thousand AUD | -67.39% |
| 1999 | 235.7 Thousand AUD | -36.6% |
| 1998 | 371.78 Thousand AUD | 282.65% |
| 1997 | 97.15 Thousand AUD | -30.01% |
| 1996 | 138.81 Thousand AUD | 9.69% |
| 1995 | 126.54 Thousand AUD | -54.56% |
| 1994 | 278.47 Thousand AUD | 33.93% |
| 1993 | 207.92 Thousand AUD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 Q2 | 20.71 Million USD | 10.22% |
| 2023 Q3 | 20.83 Million USD | 0.6% |
| 2023 Q1 | 18.79 Million USD | 34.09% |
| 2022 Q2 | 13.31 Million USD | -12.7% |
| 2022 Q4 | 14.01 Million USD | 5.3% |
| 2022 Q3 | 13.31 Million USD | -0.01% |
| 2022 Q1 | 15.24 Million USD | 4.49% |
| 2022 FY | 55.88 Million USD | -21.9% |
| 2021 FY | 71.55 Million USD | 43.62% |
| 2021 Q1 | 12.61 Million USD | 27.21% |
| 2021 Q2 | 12.95 Million USD | 2.74% |
| 2021 Q3 | 11.88 Million USD | -8.29% |
| 2021 Q4 | 14.59 Million USD | 22.83% |
| 2020 Q2 | 16.02 Million USD | -14.07% |
| 2020 FY | 49.82 Million USD | -7.68% |
| 2020 Q1 | 18.64 Million USD | 43.4% |
| 2020 Q3 | 14.34 Million USD | -10.49% |
| 2020 Q4 | 9.91 Million USD | -30.9% |
| 2019 Q1 | 12.24 Million USD | 44.86% |
| 2019 Q2 | 12.38 Million USD | 1.14% |
| 2019 Q4 | 13 Million USD | 106.79% |
| 2019 Q3 | 6.28 Million USD | -49.23% |
| 2019 FY | 53.96 Million USD | 84.5% |
| 2018 Q4 | 8.45 Million USD | -0.0% |
| 2018 FY | 29.25 Million AUD | 39.5% |
| 2018 Q3 | 8.45 Million USD | 40.24% |
| 2018 Q2 | 6.02 Million USD | 9.46% |
| 2018 Q1 | 5.5 Million USD | 44.61% |
| 2017 Q1 | 4.2 Million USD | 70.32% |
| 2017 Q4 | 3.8 Million USD | -0.0% |
| 2017 FY | 20.96 Million AUD | 34.39% |
| 2017 Q3 | 3.8 Million USD | -9.4% |
| 2017 Q2 | 4.2 Million USD | 0.0% |
| 2016 Q4 | 2.46 Million USD | -0.0% |
| 2016 FY | 15.6 Million AUD | 45.21% |
| 2016 Q2 | 3.17 Million USD | 0.0% |
| 2016 Q3 | 2.46 Million USD | -22.33% |
| 2016 Q1 | 3.17 Million USD | 13.54% |
| 2015 Q1 | 2.58 Million USD | 25.91% |
| 2015 Q2 | 2.58 Million USD | 0.0% |
| 2015 Q4 | 2.79 Million USD | -0.0% |
| 2015 Q3 | 2.79 Million USD | 8.45% |
| 2015 FY | 10.74 Million AUD | 40.3% |
| 2014 Q2 | 2.18 Million USD | 0.0% |
| 2014 FY | 7.65 Million AUD | -11.97% |
| 2014 Q4 | 2.04 Million USD | -0.0% |
| 2014 Q3 | 2.04 Million USD | -6.09% |
| 2014 Q1 | 2.18 Million USD | -2.24% |
| 2013 Q1 | 2.89 Million USD | 15.83% |
| 2013 FY | 8.69 Million AUD | -17.8% |
| 2013 Q4 | 2.23 Million USD | -0.0% |
| 2013 Q3 | 2.23 Million USD | -22.75% |
| 2013 Q2 | 2.89 Million USD | 0.0% |
| 2012 Q3 | 2.49 Million USD | -29.42% |
| 2012 Q1 | 3.53 Million USD | 0.0% |
| 2012 Q4 | 2.49 Million USD | -0.0% |
| 2012 Q2 | 3.53 Million USD | 0.0% |
| 2012 FY | 10.58 Million AUD | 9.68% |
| 2011 FY | 9.64 Million AUD | 22.37% |
| 2010 FY | 7.88 Million AUD | 50.68% |
| 2009 FY | 5.23 Million AUD | -11.52% |
| 2008 FY | 5.91 Million AUD | 2.81% |
| 2007 FY | 5.75 Million AUD | -34.27% |
| 2006 FY | 8.75 Million AUD | -9.03% |
| 2005 FY | 9.62 Million AUD | 0.0% |
| 2003 FY | 4.86 Million AUD | 2772.4% |
| 2002 FY | 169.38 Thousand AUD | -74.72% |
| 2001 FY | 670 Thousand AUD | 771.65% |
| 2000 FY | 76.86 Thousand AUD | -67.39% |
| 1999 FY | 235.7 Thousand AUD | -36.6% |
| 1998 FY | 371.78 Thousand AUD | 282.65% |
| 1997 FY | 97.15 Thousand AUD | -30.01% |
| 1996 FY | 138.81 Thousand AUD | 9.69% |
| 1995 FY | 126.54 Thousand AUD | -54.56% |
| 1994 FY | 278.47 Thousand AUD | 33.93% |
| 1993 FY | 207.92 Thousand AUD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| 4DMedical Limited | 31.48 Million AUD | -77.504% |
| Adherium Limited | 267.7 Thousand AUD | -20775.747% |
| Aroa Biosurgery Limited | 66.09 Million AUD | 15.454% |
| Atomo Diagnostics Limited | 1.6 Million AUD | -3379.757% |
| Anteris Technologies Ltd | 69.14 Million AUD | 19.183% |
| Control Bionics Limited | 9.82 Million AUD | -468.751% |
| CardieX Limited | 16.64 Million AUD | -235.666% |
| Compumedics Limited | 26.88 Million AUD | -107.906% |
| Cochlear Limited | 1.17 Billion AUD | 95.242% |
| CleanSpace Holdings Limited | 11.35 Million AUD | -391.975% |
| Cyclopharm Limited | 13.38 Million AUD | -317.65% |
| EMVision Medical Devices Ltd | 12.83 Million AUD | -335.458% |
| Nova Eye Medical Limited | 23.99 Million AUD | -132.951% |
| HeraMED Limited | 6.78 Million AUD | -723.903% |
| Imricor Medical Systems, Inc. | -1.11 Million AUD | 5108.339% |
| ImpediMed Limited | 28.04 Million AUD | -99.297% |
| InhaleRx Limited | 2.59 Million AUD | -2057.278% |
| LBT Innovations Limited | 1.1 Million AUD | -4948.329% |
| Micro-X Limited | 18.76 Million AUD | -197.831% |
| Neurotech International Limited | 8.75 Million AUD | -538.372% |
| OncoSil Medical Limited | 12.03 Million AUD | -364.167% |
| PolyNovo Limited | 34.92 Million AUD | -60.028% |
| Respiri Limited | 8.03 Million AUD | -595.532% |
| SomnoMed Limited | 58.97 Million AUD | 5.236% |
| Universal Biosensors, Inc. | 20 Million AUD | -179.422% |
| Uscom Limited | 5.52 Million AUD | -912.401% |
| Visioneering Technologies, Inc. | 9.63 Million AUD | -480.103% |